Contents

Current Drug Safety, Volume 2 - Number 3

Statin-Like Drugs for the Treatment of Brain Cholesterol Loss in Alzheimers Disease

, 2(3): 173 - 176

Biondi Elisa


DOI: 10.2174/157488607781668927




Drug Withdrawals in the United States: A Systematic Review of the Evidence and Analysis of Trends

, 2(3): 177 - 185

Amalia M. Issa, Kathryn A. Phillips, Stephanie Van Bebber, Hima G. Nidamarthy, Karen E. Lasser, Jennifer S. Haas, Brian K. Alldredge, Robert M. Wachter and David W. Bates


DOI: 10.2174/157488607781668855




The Potential of Selected Prostanoid Receptors as Targets in a New Therapeutic Strategy for Allergy and Immune Diseases

, 2(3): 186 - 192

Kenji Kabashima and Yoshiki Tokura


DOI: 10.2174/157488607781668864




Human-Based In Vitro Experimental Systems for the Evaluation of Human Drug Safety

, 2(3): 193 - 199

Albert P. Li


DOI: 10.2174/157488607781668909




QT Prolongation and Safety in the Indian Population

, 2(3): 200 - 203

Jayesh Dabhi and Anita Mehta


DOI: 10.2174/157488607781668873




Oleamide Derivatives are Prototypical Anti-Metastasis Drugs that Act by Inhibiting Connexin 26

, 2(3): 204 - 211

Hiroshi Nojima, Yusuke Ohba and Yasuyuki Kita


DOI: 10.2174/157488607781668837




Safety of Drug Eluting Stents: Current Concerns and Controversies

, 2(3): 212 - 219

Shahzad G. Raja and Geoffrey A. Berg


DOI: 10.2174/157488607781668918




Zolpidem and Traffic Safety - The Importance of Treatment Compliance

, 2(3): 220 - 226

Joris C. Verster, Edmund R. Volkerts, Berend Olivier, William Johnson and Laura Liddicoat


DOI: 10.2174/157488607781668882




Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis

, 2(3): 227 - 231

Jean-Louis Vincent


DOI: 10.2174/157488607781668846




Desmopressin 30 Years in Clinical Use: A Safety Review

, 2(3): 232 - 238

Johan Vande Walle, Mette Stockner, Ann Raes and Jens P. Norgaard


DOI: 10.2174/157488607781668891




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science